NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $7,330 | +17.9% | 421 | -37.4% | 0.00% | 0.0% |
Q4 2022 | $6,219 | +107.3% | 673 | +71.2% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 393 | +214.4% | 0.00% | -100.0% |
Q4 2021 | $4,000 | -77.8% | 125 | -66.9% | 0.00% | -66.7% |
Q3 2021 | $18,000 | +80.0% | 378 | +79.1% | 0.00% | +50.0% |
Q2 2021 | $10,000 | -23.1% | 211 | -23.0% | 0.00% | -66.7% |
Q1 2021 | $13,000 | +62.5% | 274 | +80.3% | 0.01% | +50.0% |
Q4 2020 | $8,000 | +33.3% | 152 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $6,000 | +20.0% | 152 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $5,000 | +25.0% | 152 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $4,000 | +100.0% | 152 | +117.1% | 0.00% | +100.0% |
Q4 2019 | $2,000 | 0.0% | 70 | -39.1% | 0.00% | 0.0% |
Q3 2019 | $2,000 | 0.0% | 115 | +64.3% | 0.00% | 0.0% |
Q2 2019 | $2,000 | +100.0% | 70 | +32.1% | 0.00% | – |
Q1 2019 | $1,000 | – | 53 | -10.2% | 0.00% | – |
Q3 2016 | $0 | – | 59 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 59 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |